Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference
- PMID: 25845810
- DOI: 10.1007/s00234-015-1519-3
Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference
Abstract
Introduction: Clinical presentations of prolactinomas are quite different between genders. In comparison with women's prolactinoma, those in men showed predominance of large tumors with high prolactin (PRL) levels. This preponderance could be attributed to a greater proliferative potential of the tumors. Differences in magnetic resonance imaging (MRI) signal at diagnosis have not been yet clearly evaluated.
Methods: We conduct a retrospective study comparing MRI signal intensity (SI) on T2-weighted images (T2-WI) between 41 men and 41 women to investigate whether or not men prolactinoma present specific features.
Results: In addition to the size of the adenoma and PRL levels (P < 0001), prolactinomas in men also exhibit differences from those in women in signal on T2-WI on MRI (P < 0001). Women's prolactinomas are mostly of high SI on T2-WI while men's prolactinomas exhibit a more heterogeneous pattern of SI on T2-WI. Prolactinomas presenting with low SI on T2-WI are almost exclusively encountered in men.
Conclusions: Presence of T2-WI hypointensities in pituitary adenoma can be predictive of a different subtype of prolactinoma almost encountered in men and possibly translate the presence of spherical amyloid deposits, in agreement with the literature.
Similar articles
-
Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.Pituitary. 2020 Feb;23(1):16-26. doi: 10.1007/s11102-019-01001-6. Pituitary. 2020. PMID: 31659622 Review.
-
Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.Ann Diagn Pathol. 2013 Aug;17(4):361-6. doi: 10.1016/j.anndiagpath.2013.03.001. Epub 2013 Apr 17. Ann Diagn Pathol. 2013. PMID: 23602507
-
T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.Endocrine. 2019 Feb;63(2):323-331. doi: 10.1007/s12020-018-1765-3. Epub 2018 Sep 28. Endocrine. 2019. PMID: 30267354
-
Gender-related differences in prolactin secretion in pituitary prolactinomas.Neuroradiology. 2002 May;44(5):407-10. doi: 10.1007/s00234-002-0774-2. Epub 2002 Apr 4. Neuroradiology. 2002. PMID: 12012125
-
Giant prolactinomas: the therapeutic approach.Clin Endocrinol (Oxf). 2013 Oct;79(4):447-56. doi: 10.1111/cen.12242. Epub 2013 Jun 11. Clin Endocrinol (Oxf). 2013. PMID: 23662975 Review.
Cited by
-
Clinical Biology of the Pituitary Adenoma.Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010. Endocr Rev. 2022. PMID: 35395078 Free PMC article. Review.
-
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.Nat Rev Endocrinol. 2023 Dec;19(12):722-740. doi: 10.1038/s41574-023-00886-5. Epub 2023 Sep 5. Nat Rev Endocrinol. 2023. PMID: 37670148 Review.
-
The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations.Int J Mol Sci. 2023 Nov 10;24(22):16162. doi: 10.3390/ijms242216162. Int J Mol Sci. 2023. PMID: 38003353 Free PMC article.
-
Tumor T2 signal intensity and stalk angulation correlates with endocrine status in pituitary adenoma patients: a quantitative 7 tesla MRI study.Neuroradiology. 2020 Apr;62(4):473-482. doi: 10.1007/s00234-019-02352-4. Epub 2020 Jan 10. Neuroradiology. 2020. PMID: 31925468 Free PMC article.
-
Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.Pituitary. 2020 Feb;23(1):16-26. doi: 10.1007/s11102-019-01001-6. Pituitary. 2020. PMID: 31659622 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical